REQUEST A DEMO
Total
USD $0.00
Search more companies

Lek Pharma Premium Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Beverage Manufacturing | Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Durable Goods | Retail Trade | Pipeline Transportation | Warehousing and Storage | Rental and Leasing Services | Food Services and Drinking Places
Full name: Lek Pharma Premium Sp. z o.o. Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Lek Pharma Premium Sp. z o.o. is an enterprise in Poland, with the main office in Tarnowskie Gory. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was first established on September 26, 2016. The total number of employees is currently 1 (2016).

Headquarters
Ul. Rownolegla 8
Tarnowskie Gory; Slaskie; Postal Code: 42-600

Contact Details: Purchase the Lek Pharma Premium Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Lek Pharma Premium Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Lek Pharma Premium Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Lek Pharma Premium Sp. z o.o. report to view the information.
Incorporation Date:
September 26, 2016
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lek Pharma Premium Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-13.89%
Net Profit (Loss) for the Period
-13.89%
Total equity
-90.92%
Return on Equity (ROE)
-32.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?